menu
    • menu

    Company profile for Sichuan Kelun-Biotech Biopharmaceutical

    NEW Drugs in Dev: 15
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. focuses on research, development, and manufacturing of biopharmaceutical products. With expertise in innovative drug development, clinical trials, and large-scale manufacturing, Kelun-Biotech aims to provide advanced therapeutic solutions. Their platforms support new drug research, quality manufacturing, and global commercialization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sichuan Kelun-Biotech BiopharmaceuticalChina Flag
    Country
    Country
    China
    Address
    Address
    No. 666 Xinhua Avenue Chengdu Cross-Strait Science and Technology Industry Dev...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://en.kelun-biotech.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    HKEX Approves Kelun-Biotech to Drop 'B' from Stock Code
    HKEX Approves Kelun-Biotech to Drop 'B' from Stock Code

    09 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kelun-biotech-approved-by-hkex-to-remove-b-marker-from-stock-code-representing-a-new-stage-of-development-302738138.html

    PR NEWSWIRE
    09 Apr 2026
    Share Share
    Kelun-Biotech Receives IND Approval for SKB103, Bispecific ADC
    Kelun-Biotech Receives IND Approval for SKB103, Bispecific ADC

    24 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kelun-biotech-receives-ind-approval-for-skb103-a-novel-taa-pd-l1-bispecific-adc-302723140.html

    PR NEWSWIRE
    24 Mar 2026
    Share Share
    Kelun-Biotech To Present Final Analysis Of Sac-TMT
    Kelun-Biotech To Present Final Analysis Of Sac-TMT

    18 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kelun-biotech-to-present-the-final-os-analysis-of-sacituzumab-tirumotecan-sac-tmt-from-the-optitrop-lung03-study-302717552.html

    PR NEWSWIRE
    18 Mar 2026
    Share Share
    Kelun-Biotech, Harbour Biomed Get NMPA Nod For SKB575/HBM7575
    Kelun-Biotech, Harbour Biomed Get NMPA Nod For SKB575/HBM7575

    10 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kelun-biotech-and-harbour-biomed-announce-nmpa-approval-of-ind-application-for-skb575hbm7575-for-the-treatment-of-atopic-dermatitis-302708065.html

    PR NEWSWIRE
    10 Mar 2026
    Share Share
    Kelun-Biotech Gets NMPA Approval For Sac-Tmt In HR+/HER2- Breast
    Kelun-Biotech Gets NMPA Approval For Sac-Tmt In HR+/HER2- Breast

    06 Feb 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/kelun-biotech-announces-fourth-indication-for-sacituzumab-tirumotecan-sac-tmt-approved-by-nmpa-in-hrher2--breast-cancer-302681155.html

    PR NEWSWIRE BIO
    06 Feb 2026
    Share Share
    Kelun-Biotech Highlights Innovations And Strategy At JPM Conf
    Kelun-Biotech Highlights Innovations And Strategy At JPM Conf

    15 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kelun-biotech-showcases-innovative-achievements-and-future-development-strategy-at-the-44th-annual-jpm-healthcare-conference-302662289.html

    PR NEWSWIRE
    15 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search